2025-12-07 - Analysis Report
Okay, here's a report on Intuitive Surgical Inc. (ISRG), based on the data you provided.

**Report on Intuitive Surgical Inc. (ISRG)**

**0) Overview:**

*   This report analyzes the stock performance, financial health, and market sentiment surrounding Intuitive Surgical Inc. (ISRG).

**1) Return Rate vs. S&P 500 (VOO):**

*   **Company Overview:** Intuitive Surgical is a global technology leader in robotic-assisted surgery, developing and manufacturing the da Vinci surgical system.
*   **ISRG Cumulative Return:** 110.56%
*   **VOO Cumulative Return:** 100.58%
*   **Divergence:**
    *   Current Divergence: 10.9
    *   Relative Divergence: 35.6
*   **Analysis:** ISRG has outperformed the S&P 500 over the analyzed period. The current divergence of 10.9 indicates that ISRG's cumulative return is 10.9 percentage points higher than the S&P 500. The relative divergence of 35.6 suggests that the current performance is in the lower range of its historical fluctuation.

**Alpha, Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 68.0% | 77.6% | 40.0% | -0.1 | 44.0 |
| 2016-2018  | 64.0% | 72.2% | 49.0% | -0.0 | 57.8 |
| 2017-2019  | 54.0% | 72.2% | 31.0% | 0.2 | 71.3 |
| 2018-2020  | -6.0% | 80.4% | -29.0% | 0.3 | 98.7 |
| 2019-2021  | 29.0% | 80.4% | -18.0% | 0.6 | 130.1 |
| 2020-2022  | -23.0% | 80.4% | -22.0% | 1.2 | 96.1 |
| 2021-2023  | -17.0% | 77.5% | -18.0% | 1.7 | 122.1 |
| 2022-2024  | 36.0% | 77.5% | 15.0% | 1.7 | 189.0 |
| 2023-2025  | 73.0% | 72.7% | 8.0% | 0.8 | 206.2 |

*   **CAGR:**  The Compound Annual Growth Rate shows periods of strong growth followed by periods of negative growth. The most recent period (2023-2025) shows a robust recovery.
*   **MDD:**  The Maximum Drawdown is consistently high, indicating significant volatility and potential for large price swings.
*   **Alpha:**  Alpha is generally positive in earlier periods, suggesting outperformance compared to the market. However, Alpha turns negative in several later periods, indicating underperformance.
*   **Beta:** Beta has increased over time, suggesting that ISRG's price fluctuations are becoming more correlated with the market. The shift from negative Beta (2015-2018) to positive Beta indicates a change in the stock's responsiveness to market movements.
*   **Cap(B):** Market capitalization has generally increased over time, demonstrating growth in the company's value.

**2) Recent Stock Price Fluctuations:**

*   **Current Close:** 569.71
*   **Last Market Data:** Price: 575.34, Previous Close: 568.63, Change: 1.18
*   **5-day SMA:** 569.88
*   **20-day SMA:** 563.04
*   **60-day SMA:** 499.22
*   **Analysis:** The stock price is currently above its 5-day and 20-day SMAs, suggesting a short-term upward trend. The 60-day SMA is significantly lower, indicating a longer-term upward trend as well. The slight increase in price compared to the previous close, as indicated by the last market data, suggests positive momentum.

**3) Indicators Analysis:**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment)
*   **RSI:** 48.67 (Neutral)
*   **PPO:** -0.56 (Slightly Oversold)
*   **Hybrid Signal:** Cash_0%_Buy 100% of cash (1 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-11-03)
*   **Recent (20 days) relative divergence change:** -0.9 (Short-term Decline)
*   **Expected Return (%):** 23.1%

*   **Analysis:** The MRI of 0.8 suggests a medium level of investment risk. The RSI is near 50, indicating a neutral market sentiment. The negative PPO suggests the stock may be slightly oversold, presenting a potential buying opportunity.  The hybrid signal recommends a full investment strategy. The negative change in relative divergence indicates a recent short-term decline. The 23.1% expected return suggests potential for significant future growth if held long-term.

**4) Recent News & Significant Events:**

*   **Positive Coverage:**
    *   "High Margins, 12% Discount: Buy Intuitive Surgical Stock Now" suggests potential undervaluation.
    *   "Intuitive Surgical Stock: Buy Opportunity or Risk Ahead" highlights potential upside.
    *   "Intuitive Surgical: Strong Fundamentals, Yet Market Price Reflects Most Opportunity" suggests underlying strength.

*   **Institutional Investment:** "First Trust Advisors LP Has $100.47 Million Stock Holdings in Intuitive Surgical, Inc." indicates confidence from institutional investors.

*   **Mixed Sentiment:**
    *   "Intuitive Surgical (ISRG) Fell Despite Reporting Strong Results" suggests market disappointment despite positive earnings.
    *   "What Intuitive Surgical (ISRG)'s Strong Procedure Growth and Cautious Margin Outlook Means For Shareholders" highlights both positive and potentially negative aspects of the company's outlook.

*   **Overall:** Recent news presents a mixed picture. While several articles suggest positive fundamentals and a potential buying opportunity, others highlight concerns about market reaction to earnings and cautious margin outlooks.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy
*   **Mean Rating:** 2.00 (~Buy)
*   **Number of Opinions:** 29
*   **Target Price:**
    *   Average: 596.36
    *   High: 700.00
    *   Low: 378.00
*   **Analysis:** The consensus among analysts is to "Buy" ISRG, and the average target price of $596.36 suggests an upside potential from the current price. However, the wide range between the high and low target prices indicates varying opinions on the stock's future performance. No changes on recent rating change history.

**5) Recent Earnings Analysis:**

| Date       | EPS  | Revenue   |
|------------|------|-----------|
| 2025-10-22 | 1.98 | 2.51 B$   |
| 2025-07-23 | 1.84 | 2.44 B$   |
| 2025-04-23 | 1.95 | 2.25 B$   |
| 2024-10-18 | 1.59 | 2.04 B$   |
| 2025-10-22 | 1.59 | 2.04 B$   |

*   **Analysis:** Both EPS and revenue have generally increased over the past few quarters, indicating strong financial performance. There appears to be an error in your data with a duplicated entry for "2025-10-22" and "2024-10-18" showing identical figures. The most recent quarter shows the highest EPS and revenue in the provided data.

**6) Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2025-09-30   | $2.51B  | 66.36%        |
| 2025-06-30   | $2.44B  | 66.31%        |
| 2025-03-31   | $2.25B  | 64.69%        |
| 2024-12-31   | $2.41B  | 68.04%        |
| 2024-09-30   | $2.04B  | 67.41%        |

*   **Analysis:** Revenue has shown consistent growth over the past year, with the latest quarter reporting the highest figure. Profit margins remain strong, consistently above 64%.

**Capital and Profitability:**

| Quarter      | Equity    | ROE    |
|--------------|-----------|--------|
| 2025-09-30   | $16.93B   | 4.16%  |
| 2025-06-30   | $17.85B   | 3.69%  |
| 2025-03-31   | $17.11B   | 4.08%  |
| 2024-12-31   | $16.43B   | 4.17%  |
| 2024-09-30   | $15.58B   | 3.63%  |

*   **Analysis:** Equity has generally increased over the period, indicating a strengthening financial position. Return on Equity (ROE) has fluctuated but remains relatively stable, indicating consistent profitability relative to equity.

**7) Comprehensive Analysis (Summary):**

*   **Performance:** ISRG has outperformed the S&P 500 in the analyzed period, although historical data reveals periods of underperformance. Recent short-term decline.
*   **Financials:** The company demonstrates strong financial health with growing revenue, high profit margins, and increasing equity.
*   **Market Sentiment:** Analyst consensus leans towards "Buy," and target prices suggest upside potential. However, mixed news coverage and varying analyst opinions highlight potential risks.
*   **Indicators:** The MRI indicates a medium level of investment risk. The neutral RSI and slightly oversold PPO suggest a potential buying opportunity.
*   **Overall:** Intuitive Surgical appears to be a fundamentally strong company with growth potential. However, investors should be aware of the inherent volatility and potential for market fluctuations, as indicated by the high MDD and mixed news coverage. A long-term investment horizon may be beneficial to realize the expected return.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.